This company listing is no longer active
R1 RCM Future Growth
Future criteria checks 4/6
R1 RCM is forecast to grow earnings and revenue by 62.1% and 12.2% per annum respectively. EPS is expected to grow by 62.7% per annum. Return on equity is forecast to be 4.9% in 3 years.
Key information
62.1%
Earnings growth rate
62.7%
EPS growth rate
Healthcare earnings growth | 27.6% |
Revenue growth rate | 12.2% |
Future return on equity | 4.9% |
Analyst coverage | Good |
Last updated | 19 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3,268 | 155 | 459 | 631 | 6 |
12/31/2025 | 2,954 | 73 | 284 | 435 | 9 |
12/31/2024 | 2,552 | -80 | 126 | 257 | 3 |
9/30/2024 | 2,464 | -61 | 186 | 291 | N/A |
6/30/2024 | 2,380 | -40 | 203 | 312 | N/A |
3/31/2024 | 2,313 | -33 | 229 | 332 | N/A |
12/31/2023 | 2,254 | 3 | 238 | 340 | N/A |
9/30/2023 | 2,212 | -35 | 151 | 251 | N/A |
6/30/2023 | 2,135 | -65 | 68 | 168 | N/A |
3/31/2023 | 1,966 | -91 | -93 | 13 | N/A |
12/31/2022 | 1,806 | -63 | -103 | -10 | N/A |
9/30/2022 | 1,672 | -1 | -95 | -2 | N/A |
6/30/2022 | 1,556 | 45 | -13 | 63 | N/A |
3/31/2022 | 1,518 | 91 | 189 | 242 | N/A |
12/31/2021 | 1,475 | -505 | 205 | 257 | N/A |
9/30/2021 | 1,404 | -495 | 190 | 230 | N/A |
6/30/2021 | 1,332 | -512 | 108 | 145 | N/A |
3/31/2021 | 1,293 | -526 | 62 | 107 | N/A |
12/31/2020 | 1,270 | 47 | 11 | 60 | N/A |
9/30/2020 | 1,256 | 14 | 61 | 121 | N/A |
6/30/2020 | 1,250 | 16 | 55 | 115 | N/A |
3/31/2020 | 1,231 | 3 | -16 | 43 | N/A |
12/31/2019 | 1,186 | -9 | 53 | 114 | N/A |
9/30/2019 | 1,135 | -22 | 11 | 68 | N/A |
6/30/2019 | 1,084 | -42 | 33 | 83 | N/A |
3/31/2019 | 997 | -41 | 54 | 99 | N/A |
12/31/2018 | 869 | -64 | -15 | 18 | N/A |
9/30/2018 | 746 | -99 | -4 | 19 | N/A |
6/30/2018 | 619 | -88 | N/A | 23 | N/A |
3/31/2018 | 510 | -92 | N/A | 39 | N/A |
12/31/2017 | 450 | -76 | N/A | 21 | N/A |
9/30/2017 | 416 | -28 | N/A | -22 | N/A |
6/30/2017 | 418 | -3 | N/A | -57 | N/A |
3/31/2017 | 327 | -36 | N/A | -116 | N/A |
12/31/2016 | 593 | 65 | N/A | -87 | N/A |
9/30/2016 | 555 | 68 | N/A | -100 | N/A |
6/30/2016 | 445 | 17 | N/A | -57 | N/A |
3/31/2016 | 458 | 35 | N/A | -8 | N/A |
12/31/2015 | 117 | -84 | N/A | -24 | N/A |
9/30/2015 | 96 | -107 | N/A | -39 | N/A |
6/30/2015 | 171 | -65 | N/A | -23 | N/A |
3/31/2015 | 208 | -55 | N/A | -71 | N/A |
12/31/2014 | 210 | -80 | N/A | -77 | N/A |
9/30/2014 | 247 | -56 | N/A | -22 | N/A |
6/30/2014 | 174 | -103 | N/A | -47 | N/A |
3/31/2014 | 490 | 102 | N/A | 28 | N/A |
12/31/2013 | 505 | 130 | N/A | 54 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 6HL0 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: 6HL0 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 6HL0 is expected to become profitable in the next 3 years.
Revenue vs Market: 6HL0's revenue (12.2% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 6HL0's revenue (12.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 6HL0's Return on Equity is forecast to be low in 3 years time (4.9%).